Pharmacists' Willingness to Offer Vaccination Services: A Systematic Review and Meta-Analysis.

Pharmacy (Basel)

School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

Published: June 2024

Pharmacy-based vaccination (PBV) services increase coverage and enhance access to lifesaving vaccines. This systematic review assessed the proportion of pharmacists willing to offer PBV services. PubMed/MEDLINE, CINAHL, EMBASE and Scopus electronic databases were searched from inception to identify relevant literature. Google scholar and other sources of grey literature was also searched. The literature findings were synthesized narratively, and via a random-effects meta-analysis. Risk of bias was evaluated using nine quality assessment criteria adapted from the Joanna Briggs Institute checklist for prevalence studies. The review protocol is registered on PROSPERO (REF: CRD42021293692). In total, 967 articles were identified from the literature search. Of this, 34 articles from 19 countries across 5 WHO regions were included in the review. No article from the Western Pacific WHO region was identified. Most of the included studies (n = 21, 61.8%) showed an overall low risk of bias. None showed a high risk of bias. Pooled willingness for PBV services was 69.45% (95% CI: 61.58-76.33; n total pharmacists = 8877), indicating that most pharmacists were willing to offer the service, although nearly a third were not. Pharmacists' willingness was highest in the Americas (71.49%, 95% CI: 53.32-84.63, n pharmacists = 3842) and lowest in the African region (58.71%, 95% CI: 45.86-70.46, n pharmacists = 1080) although the between-group difference was not statistically significant across the WHO regions (Q = 3.01, df = 4, < 0.5567). Meta-regression showed no evidence (R = 0%, = 0.9871) of the moderating effect of the type of vaccine assessed, PBV service availability, sampling technique and the study risk of bias. These findings show that most pharmacists are willing to offer PBV services; however, strategies that will enhance greater involvement in service provision are needed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11270253PMC
http://dx.doi.org/10.3390/pharmacy12040098DOI Listing

Publication Analysis

Top Keywords

pbv services
16
risk bias
16
pharmacists offer
12
pharmacists' willingness
8
systematic review
8
offer pbv
8
pharmacists
6
services
5
pbv
5
offer
4

Similar Publications

Pharmacists' Willingness to Offer Vaccination Services: A Systematic Review and Meta-Analysis.

Pharmacy (Basel)

June 2024

School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

Pharmacy-based vaccination (PBV) services increase coverage and enhance access to lifesaving vaccines. This systematic review assessed the proportion of pharmacists willing to offer PBV services. PubMed/MEDLINE, CINAHL, EMBASE and Scopus electronic databases were searched from inception to identify relevant literature.

View Article and Find Full Text PDF

The diversification of mobility into services such as smart stores and conference rooms has accelerated the development of purpose-built vehicles (PBVs)-vehicles designed for specific purposes that utilize an extended electric vehicle chassis and autonomous driving technology. Despite the standards on speed bump dimensions stipulated by the National Land Transportation Act of the Republic of Korea, real-world speed bumps feature varying widths and heights that deviate from these standards. In this study, a velocity equation was derived via regression analysis to achieve the desired dynamic characteristics for a PBV passing over speed bumps with varying shapes through two types of semi-active suspension control: proportional-integral-differential (PID) and linear-quadratic-regulator (LQR).

View Article and Find Full Text PDF
Article Synopsis
  • Benfotiamine is being tested as a new oral treatment option for early Alzheimer's disease (AD), potentially enhancing the effects of existing therapies targeting amyloid.
  • A 72-week randomized, double-blind, placebo-controlled trial will investigate its safety, tolerability, and efficacy in 406 participants, starting with a phase 2A to find the optimal dose before moving to phase 2B.
  • The trial's innovative design allows for a smooth transition between phases, aiming to confirm benefits through specific cognitive and safety assessments.
View Article and Find Full Text PDF

Introduction: Higher rates of mental health conditions, increased incidence of psychiatric diagnoses, and symptom relapse with minimal access to psychotherapeutic services are reported during the COVID-19 pandemic. A local area clinic in the United States that exists to serve underprivileged patients helps to combat poor psychiatric outcomes by offering psychiatric clinics, pharmacotherapy management, and medications at reduced or no cost.

Methods: Recruitment and data collection were conducted from May 3, 2021, to March 3, 2022.

View Article and Find Full Text PDF

Variability in PET image quality and quantification measured with a permanently filled Ge-phantom: a multi-center study.

EJNMMI Phys

June 2023

Clinical Physiology and Nuclear Medicine, Central Finland Health Care District, Jyväskylä, Finland.

Background: This study evaluated, as a snapshot, the variability in quantification and image quality (IQ) of the clinically utilized PET [F]FDG whole-body protocols in Finland using a NEMA/IEC IQ phantom permanently filled with Ge.

Methods: The phantom was imaged on 14 PET-CT scanners, including a variety of models from two major vendors. The variability of the recovery coefficients (RC, RC and RC) of the hot spheres as well as percent background variability (PBV), coefficient of variation of the background (COV) and accuracy of corrections (AOC) were studied using images from clinical and standardized protocols with 20 repeated measurements.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!